ABP
vs
T
2617

Over the past 12 months, ABP has underperformed TransThera Sciences (Nanjing) Inc, delivering a return of -97% compared to the TransThera Sciences (Nanjing) Inc's +34% growth.
Smart Verdict
AI-Powered
Let AI Decide.


Valuation Comparison

Growth Comparison
Growth Over Time
ABP, 2617
All metrics are calculated based on data from the last 10 years.
Profitability Comparison
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE
Solvency Comparison

